[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Strauss et al., 1986 - Google Patents

Medical concerns in the application of ultrashort-lived radionuclides

Strauss et al., 1986

View PDF
Document ID
5412568450001483183
Author
Strauss H
Gill J
Miller D
Elmaleh D
Publication year
Publication venue
Fourth International Radiopharmaceutical Dosimetry Symposium

External Links

Snippet

The dosiraetry of ultrashort-lived radionuclides is dependent on the biodistribution and residence time of the materials eluted from the generator. Since the half-life of the daughter usually precludes any serious chemical manipulations, the eluates are usually infused in the …
Continue reading at citeseerx.ist.psu.edu (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/0474—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255—Granulates, agglomerates, microspheres
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01T—MEASUREMENT OF NUCLEAR OR X-RADIATION
    • G01T1/00—Measuring X-radiation, gamma radiation, corpuscular radiation, or cosmic radiation
    • G01T1/16—Measuring radiation intensity
    • G01T1/161—Application in the field of nuclear medicine, e.g. in vivo counting
    • G01T1/164—Scintigraphy
    • G01T1/1641—Static instruments for imaging the distribution of radioactivity in one or two dimensions using one or several scintillating elements; Radio-isotope cameras
    • G01T1/1648—Ancillary equipment for scintillation cameras, e.g. reference markers, devices for removing motion artifacts, calibration devices
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G4/00—Radioactive sources
    • G21G4/04—Radioactive sources other than neutron sources
    • G21G4/06—Radioactive sources other than neutron sources characterised by constructional features
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005—Isotope delivery systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K2121/00—Preparations for use in therapy

Similar Documents

Publication Publication Date Title
Wackers et al. Gold-195m, a new generator-produced short-lived radionuclide for sequential assessment of ventricular performance by first pass radionuclide angiocardiography
Mena et al. Gold-195m, an ultra-short-lived generator-produced radionuclide: clinical application in sequential first pass ventriculography
Treves et al. Angiocardiography with iridium-191m: an ultrashort-lived radionuclide (T1/2 4.9 sec).
Strauss et al. Medical concerns in the application of ultrashort-lived radionuclides
Heller et al. Comparison of ultrashort-lived iridium-191m with technetium-99m for first pass radionuclide angiocardiographic evaluation of right and left ventricular function in adults
Strauss et al. Cardiac nuclear imaging: Principles, instrumentation and pitfalls
Budinger et al. ‘Positron-emission tomography (PET)
Beller et al. Positron emission tomographic imaging of the myocardium with 81Rb
Kaplan et al. Definition of myocardial perfusion by continuous infusion of krypton-81m
Colombetti Radionuclide generators
Goldberg et al. Intravenous xenon-133 for the determination of radionuclide first pass right ventricular ejection fraction
Elliott et al. A 195Hgm-195Aum generator for use in first-pass nuclear angiocardiography
Ryan et al. KADIATION ABSORBED DOSE ESTIMATE FOR RDBIDIOM-82 DETEIMZNED FROM IN VIVO MEASUREMENTS IN HUMAN SUBJECTS
US20240249856A1 (en) Systems for radioisotope generation and methods of preparation and administration
OBE et al. The Use of Radionuclides in Molecular Imaging and Molecular Radiotherapy
Wiebe Radionuclides, Radiotracers and Radiopharmaceuticals for in vivo Diagnosis
Treves et al. Rapid renal single-photon emission tomography by continuous infusion of iridium-191m
WO2024116108A1 (en) Improved and safe techniques for use of radioactive generator
Lindner et al. Quantitative activation patterns of cerebral blood flow during mental stimulation after intravenous injection of 195mAu
Raichle Positron-emission tomography
Mushtaq Inorganics in Nuclear Medicine
Landsberger et al. Development Of A Radiochemistry Laboratory For The Production Of Tc 99 M Using Neutron Activation
CA3208240A1 (en) Improved dosing method for positron emission tomography imaging
Haggith The importance and required detection levels of radionuclide impurities—A medical physicist's view
Rahman Pharmacokinetics, bio-distribution and dosmimetry of some widely used radiopharmaceuticals in nuclear medicine under Bangladesh condition